IP Library Granted Patent US 8,217,123
Granted Patent B2
US 8,217,123 · App. 12/943,740 · Granted Jul 10, 2012

Stabilized polymeric thiol reagents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,217,123
App. No.
12/943,740
Granted
Jul 10, 2012
Kind
B2
Abstract

Disclosed are water soluble polymeric reagents comprising the structure POLY-[Y—S—W] x , where POLY is a water soluble polymer; Y is a hydrocarbon-based spacer group, x is 1 to 25, and S—W is a thiol, protected thiol, or thiol-reactive derivative. Preferably, the water soluble polymer is a PEG polymer. Also disclosed are conjugates of such polymeric reagents with pharmaceutically relevant molecules, and methods of their formation and use.

Claims (13)

1. A polymer conjugate comprising the structure:

POLY A -L-S—S—Y-POLY B -Y—S—S-A

wherein:

each of POLY A and POLY B is a water soluble polymer segment, where POLY B has a molecular weight of 10 KDa or less, and the sum of the molecular weights of POLY A and POLY B is at least 3 KDa; each Y is independently a divalent linking group consisting of a saturated or unsaturated hydrocarbon backbone which is three to ten carbon atoms in length and has substituents which are independently selected from hydrogen, lower alkyl, lower alkenyl, and non-interfering substituents as defined herein, where two such alkyl and/or alkenyl substituents on different carbon atoms of the backbone may be linked so as to form a cycloalkyl, cycloalkenyl, or aryl group;

L is a linker group;

each S—S is a disulfide group attached to an sp 3 hybridized carbon of the adjacent Y; and

A is a covalently linked residue of a pharmacologically active molecule.

2. The conjugate of claim 1 , wherein each Y is independently —(CR 1 R 2 )n-, where n is 3 to 10, each of R 1 and R 2 is independently selected from hydrogen, alkyl, alkenyl, and a non-interfering substituent, and where two groups R 1 and R 2 on different carbon atoms may be linked to form a cycloalkyl or aryl group.

3. The conjugate of claim 2 , where n is 3 to 8.

4. The conjugate of claim 1 , wherein POLY A has a molecular weight of at least 5 KDa.

5. The conjugate of claim 2 , wherein the two Y groups are identical.

6. The conjugate of claim 2 , wherein each Y is a linear or branched alkylene having the formula —(CR 1 R 2 )n-, where n is 3 to 8, and each of R 1 and R 2 is independently selected from hydrogen and lower alkyl.

7. The conjugate of claim 1 , wherein each of POLY A and POLY B is a polyethylene glycol.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →